Evidence map›Paper›PMID 26419467›Full record

ReviewCurrent osteoporosis reports2015

A Mechanism-Based Approach to the Management of Osteoarthritis Pain.

Ezra Cohen, Yvonne C Lee

Abstract readReview
In one paragraph

Review in Current osteoporosis reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Mesenchymal stem cells in osteoarthritis therapy: a review.American journal of translational research · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ezra CohenDepartment of Rheumatology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. Ezra.cohen@childrens.harvard.edu.
Yvonne C LeeDepartment of Rheumatology, Brigham and Women's Hospital, 75 Francis St., Boston, MA, 02115, USA. Ylee9@partners.org.

Funding

MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain TransitionR01AR064850 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEE, YVONNE CLAIRE · 2013 to 2025
$7.9M
NIAID NIH HHS T32 AI007512NIAMS NIH HHS R01 AR064850
6 · The paper itself

Abstract

Pain from osteoarthritis (OA) affects millions of people worldwide, yet treatments are limited to acetaminophen, NSAIDs, physical therapy, and ultimately, surgery when there is significant disability. In recent years, our understanding of pain pathways in OA has developed considerably. Though joint damage and inflammation play a significant role in pain generation, it is now understood that both central and peripheral nervous system mechanisms exacerbate symptoms. Evolving management strategies for OA address central factors (e.g., sleep difficulties, catastrophizing, and depression) with treatments such as cognitive behavioral therapy and exercise. In addition, emerging data suggest that antibodies against peripheral signaling neuropeptides, such as nerve growth factor-1 (NGF-1), may significantly alleviate pain. However, concerns regarding potential adverse effects, such as rapidly progressive OA, still remain. A nuanced understanding is essential if we are to make headway in developing more effective treatments for OA.

Indexed as

Central Nervous System SensitizationCognitive Behavioral TherapyPhysical Therapy ModalitiesAnti-Inflammatory Agents, Non-SteroidalArthroplasty, ReplacementCapsaicinCatastrophizationDepressionExercise TherapyGlucosamineHumansHyaluronic AcidNerve Growth FactorOsteoarthritisPainPain ManagementAnti-Inflammatory Agents, Non-SteroidalCapsaicinGlucosamineHyaluronic AcidNerve Growth FactorSensory System AgentsViscosupplementsCentral sensitizationMusculoskeletal painNGFOsteoarthritisPain mechanisms

Identifiers

PMID26419467
PMCPMC4623875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.